GlassScriptPhysician profile
Grace Emily Arnold
NPI 1639772924
$1,690.24
in general payments reported to CMS, 2019-2025
13 companies · $840 in 2025
The $840 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.95 · 2023: $260 · 2024: $575 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $516.76 | 2023-2025 | Biotrue One Day, Infuse, Xiidra |
| Tarsus Pharmaceuticals, INC. | $308.44 | 2024-2025 | Xdemvy |
| Coopervision INC. | $210.44 | 2023-2024 | Cvi Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $210.27 | 2022-2025 | Acuvue |
| Alcon Vision LLC | $125.65 | 2023-2025 | Dailies Total1, Tryptyr, Total30 |
| Oyster Point Pharma, INC. | $74.51 | 2023-2024 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $67.88 | 2025 | Acthar |
| Dompe US, INC. | $44.09 | 2025 | Oxervate |
| Abbvie INC. | $40.15 | 2025 | |
| Harrow Eye, LLC | $28.56 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $24.48 | 2025 | |
| Astellas Pharma US INC | $20.94 | 2024 | Izervay |
| Thea Pharma INC. | $18.07 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.